EG-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EG-101, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia [Phase 1]